Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121322913 | 12132291 | 3 | F | 20160109 | 20160727 | 20160301 | 20160801 | PER | US-CELGENEUS-USA-2016025143 | CELGENE | 78.74 | YR | F | Y | 73.09000 | KG | 20160801 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121322913 | 12132291 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | 15 MILLIGRAM | U | U | UNKNOWN | 21880 | 15 | MG | CAPSULES | ||||
| 121322913 | 12132291 | 2 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | U | U | UNKNOWN | 0 | 2.2 | MG | UNKNOWN | |||||
| 121322913 | 12132291 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 2.2 MILLIGRAM | U | U | UNKNOWN | 0 | 40 | MG | UNKNOWN | /wk | |||
| 121322913 | 12132291 | 4 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 121322913 | 12132291 | 5 | C | LASIX | FUROSEMIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 121322913 | 12132291 | 6 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 121322913 | 12132291 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 121322913 | 12132291 | 8 | C | ACYCLOVIR. | ACYCLOVIR | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121322913 | 12132291 | 1 | Plasma cell myeloma |
| 121322913 | 12132291 | 2 | Plasma cell myeloma |
| 121322913 | 12132291 | 3 | Plasma cell myeloma |
| 121322913 | 12132291 | 4 | Product used for unknown indication |
| 121322913 | 12132291 | 5 | Product used for unknown indication |
| 121322913 | 12132291 | 6 | Product used for unknown indication |
| 121322913 | 12132291 | 7 | Product used for unknown indication |
| 121322913 | 12132291 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121322913 | 12132291 | HO |
| 121322913 | 12132291 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121322913 | 12132291 | Anaemia | |
| 121322913 | 12132291 | Diarrhoea | |
| 121322913 | 12132291 | Osteomyelitis | |
| 121322913 | 12132291 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121322913 | 12132291 | 1 | 20151124 | 20160209 | 0 | |
| 121322913 | 12132291 | 2 | 20151102 | 20160204 | 0 | |
| 121322913 | 12132291 | 3 | 20151102 | 20160209 | 0 |